来自MSN3 个月
Nonsteroidal Topical OK'd for Atopic Dermatitis
The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on Monday. Approval of the topical aryl hydrocarbon receptor agonist was ...
Managed Healthcare Executive13 天
Drug Holidays Possible with Vtama in Atopic Dermatitis
A break from treatment with Vtama won’t lead to worsening of patients’ atopic dermatitis, finds a new analysis of an ...
Healio12 天
Adults, children maintain mild AD during treatment-free period follow Vtama cream 1%
Atopic dermatitis disease activity remained mild after patients treated with Vtama cream 1% achieved nearly 80 consecutive ...
The American Journal of Managed Care7 天
Atopic Dermatitis Treatment Strategies Using Ruxolitinib, Considering Crucial Role of Skin ...
Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...